StonvexLoading…
StonvexStonvexStonvexCore line items from CRWV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $5.13B | $1.92B | $229.00M |
Operating Income | $-46.00M | $324.00M | $-14.00M |
Net Income | $-1.17B | $-863.00M | $-594.00M |
EPS (Diluted) | $-2.81 | $-4.30 | $-3.09 |
Total Assets | $49.30B | $17.83B | Not available |
Total Liabilities | $45.97B | $16.52B | Not available |
Cash & Equivalents | $3.13B | $1.36B | $217.00M |
Free Cash Flow OCF − CapEx | $-7.25B | $-5.95B | $-1.11B |
Shares Outstanding | 436.00M | 218.00M | 192.00M |